EDGAR Filing Documents for 0001116679-07-000161

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001116679-07-000161

Filing Date

2007-01-16

Accepted

2007-01-16 16:13:37

Documents

Period of Report

2007-01-12

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	edgar.html	4
1	PRIMARY DOCUMENT	edgar.xml	4	3940
	Complete submission text file	0001116679-07-000161.txt		5872

Mailing Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154

Business Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154 212-750-6700

IRS No.: 113375915 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOENVISION, INC. 509 MADISON AVE., SUITE 404 NEW YORK NY 10022

Business Address 212-750-6700

Type: 4 | Act: 34 | File No.: 001-31787 | Film No.: 07532209